论文信息 - Sorafenib has potent antitumor activity against multiple myeloma in vitro, ex vivo, and in vivo in the 5T33MM mouse model. - 字舞流文

Sorafenib has potent antitumor activity against multiple myeloma in vitro, ex vivo, and in vivo in the 5T33MM mouse model.

B. Zhivotovsky | P. Johnsson | D. Grandér | M. Björkholm | E. Laane | Qiao Li | A. Osterborg | T. Panaretakis | A. Gruber | K. Vanderkerken | H. de Raeve | H. Jernberg-Wiklund | P. Kharaziha | G. Kokaraki | F. Celsing | Charlotte Fristedt | Maria Panzar